How should elevated iron levels be evaluated and managed?

Evaluation and Management of Elevated Iron Levels

Begin evaluation with serum transferrin saturation (TSAT) and ferritin, then determine if true iron overload exists or if hyperferritinemia is secondary to inflammation, liver disease, metabolic syndrome, or alcohol use—this distinction drives all subsequent management decisions 1.

Initial Diagnostic Algorithm

Step 1: Measure Iron Parameters

• Transferrin saturation (TSAT) and serum ferritin are your first-line tests 1
• Serum iron and total iron binding capacity provide additional differential diagnostic information 1
• Do NOT measure hepcidin—it has no clinical utility 1

Step 2: Interpret Results Based on Thresholds

True iron overload is suggested when:

• Males: TSAT ≥50% AND ferritin >300 μg/L 2
• Females: TSAT ≥40-45% AND ferritin >200 μg/L 1, 2

Hyperferritinemia WITHOUT iron overload occurs when:

• Elevated ferritin but normal/low TSAT
• Consider: inflammation, infection, malignancy, liver disease (cytolysis), metabolic syndrome, excessive alcohol intake, or hereditary hyperferritinemia 2, 3, 4

Genetic Testing for Hereditary Hemochromatosis

Proceed with HFE genetic testing (C282Y and H63D variants) when TSAT and ferritin are both elevated as defined above 1, 4. This has 100% consensus recommendation 1.

Genotype-Specific Management:

• C282Y homozygotes: Proceed directly to treatment planning; MRI quantification optional but helpful for predicting phlebotomy burden 1
• C282Y/H63D compound heterozygotes: Manage based on phenotype and additional risk factors, not genotype alone 1
• H63D homozygotes: Iron overload is rare (3.2%); investigate other causes if iron overload confirmed 1

Advanced Imaging When Needed

Use MRI with R2 sequences to quantify hepatic iron concentration when:*

• Genetic testing is negative but iron overload suspected 1
• Additional risk factors present (metabolic syndrome, alcohol use, chronic liver disease) 1
• Unclear diagnosis with positive liver iron staining 1
• Assessing extrahepatic organ involvement (pancreas, heart, spleen) 1

Cardiac MRI specifically indicated for:

• Signs of heart disease in hemochromatosis patients 1
• Juvenile hemochromatosis forms 1

Liver Assessment

Perform liver biopsy or elastography when:

• Serum ferritin >1,000 μg/L (to assess for cirrhosis/advanced fibrosis) 1, 3
• Liver enzymes are elevated 1
• Do NOT biopsy if cirrhosis already clinically evident 1

Treatment Decisions

Therapeutic Phlebotomy Indications

Initiate phlebotomy for confirmed hereditary hemochromatosis when:

• Males: ferritin ≥300 μg/L 5
• Females: ferritin ≥200 μg/L 5
• Regardless of symptoms 5

Phlebotomy protocol:

1. Induction phase: Remove 450-500 mL weekly until ferritin reaches 10-20 μg/L 5
2. Maintenance phase: Keep ferritin ≤50 μg/L with periodic phlebotomy 5

When NOT to Use Phlebotomy

Dysmetabolic iron overload syndrome (metabolic syndrome with mild hepatic iron elevation): Phlebotomy is poorly tolerated without clear benefit—avoid routine use 3.

Iron Chelation Therapy

Reserve chelators for iron overload with anemia (myelodysplastic syndromes, transfusion-dependent thalassemia) 3:

• Initiate when hepatic iron content >120 μmol/g 3
• Deferasirox: First-line oral agent 3
• Deferiprone: Alternative despite neutropenia risk 3
• Deferoxamine: Parenteral route for severe/emergency iron overload 3

Critical Lifestyle Modifications

Alcohol Restriction

Strictly limit or avoid alcohol in the presence of iron overload, organ disease, or liver abnormalities—heavy alcohol intake dramatically increases risk of fibrosis and hepatocellular carcinoma 1.

Dietary Precautions

• Avoid medicinal iron and mineral supplements 5
• Avoid excess vitamin C (increases iron absorption) 5
• Absolutely avoid raw/uncooked seafood—patients with iron overload face >50% mortality from Vibrio vulnificus sepsis due to hepcidin deficiency enabling rapid bacterial growth 1

Weight Management

Recommend weight loss through diet and physical activity in patients with fatty liver disease 1.

Common Pitfalls to Avoid

1. Don't assume elevated ferritin equals iron overload—ferritin is an acute-phase reactant; always check TSAT 2, 3
2. Don't treat H63D homozygotes or C282Y/H63D compound heterozygotes based on genotype alone—phenotype and additional risk factors determine management 1
3. Don't perform genetic testing before checking iron parameters—biochemical screening comes first 1
4. Don't overlook secondary causes when HFE testing is negative: hematologic disorders (thalassemia, myelodysplastic syndrome, sickle cell disease), chronic liver disease, or iatrogenic causes 4

Family Screening

Test all first-degree adult relatives (>18 years) of C282Y homozygous patients with genetic testing after informed consent 1. This has 100% consensus recommendation.